Skip to main content
Log in

Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Resistance to activated protein C (APCR) is the most common genetic risk factor for venous thrombosis and is generally caused by a mutation in the factor V (FV) gene leading to FV Leiden. The recent finding of FV Leiden in three of seven patients with dural arteriovenous fistulas (DAVFs) prompted us to evaluate systematically the role of APCR due to FV Leiden in the pathogenesis of DAVFs in 22 patients and age- and sex-matched controls. We found a significantly higher frequency of APCR and FV Leiden in the patient group than among controls (5/22 vs. 0/22, P=0.048, Fisher's exact test). We conclude that APCR due to FV Leiden is of pathogenetic significance in a subgroup of DAVFs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 10 December 1999, Received in revised form: 12 January 2000, Accepted: 16 February 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kraus, J., Stüper, B., Nahser, HC. et al. Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas. J Neurol 247, 521–523 (2000). https://doi.org/10.1007/s004150070150

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004150070150

Navigation